Table 3.
Variable | Total (N = 135) | Controls (N = 65) | Non-shock (N = 39) | Septic shock (N = 96) | p-value |
---|---|---|---|---|---|
MASP-1, AU/L | 7.6 [6.5–8.9] | 8.7 [7.5–10.2]a | 8.4 [6.8–9.3] | 7.4 [6.3–8.7]b | 0.0017 |
MASP-2, AU/L | 793.4 [504.1–1121.0] | 977.5 [623.3–1464.3] | 905.1 [551.9–1422.5] | 717.3 [487.6–1015.0] | 0.0390 |
MASP-3, AU/L | 65.4 [47.5–100.5] | 109.3 [87.9–130.1]ca | 65.4 [48.4–86.2]b | 65.5 [46.5–113.7]b | <0.0001 |
C4, g/Ld | 0.17 [0.14–0.24] | 0.24 [0.20–0.31]ca | 0.17 [0.14–0.26]b | 0.17 [0.13–0.24]b | <0.0001 |
C4c AU/L | 134.6 [87.3–199.0] | 194.7 [130.9–326.5]a | 158.2 [106.1–261.4] | 125.9 [80.7–188.8]b | <0.0001 |
C4c/C4d | 752.9 [507.1–1165.8] | 855.3 [569.8–1391.0] | 958.6 [522.1–1442.3] | 671.5 [506.0–1086.0] | 0.0828 |
C3, g/Ld | 0.93 [0.75–1.2] | 1.2 [1.1–1.4]ca | 1.04 [0.82–1.4]ba | 0.89 [0.73–1.08]bc | <0.0001 |
C3bc, AU/L | 15.7 [9.2–24.2]14.7 [9.1–22.0] | 12.5 [9.1–18.4] | 17.0 [9.5–22.4] | 15.6 [9.1–24.2] | 0.2460 |
C3bc/C3d | 16.5 [10.3–27.0] | 10.7 [7.7,14.7]ca | 15.2 [9.3,23.0]b | 16.7 [10.4,27.3]b | 0.0002 |
TCC AU/L | 1.5 [1.00–2.6] | 0.35 [0.26–0.46]ca | 1.3 [0.68–1.8]ba | 1.7 [1.1–2.8]bc | <0.0001 |
Leukocyte count, × 10/l, highest value | 16.9 [10.4–23.9] | 7.2 [6.3–9.3]ca | 15.5 [9.7–22.7]b | 17.6 [12.3–24.4]b | <0.0001 |
C-reactive protein, mg/Ld | 222.0 [141.0–298.0] | 2.0 [1.00–4.0]ca | 201.0 [134.0–275.0]b | 222.0 [154.0–301.5]b | <0.0001 |
Albumin, g/L | 20.0 [16.0–22.0] | 39.0 [36.0–41.0]ca | 21.0 [18.0–23.0]b | 18.5 [15.0–22.0]b | <0.0001 |
Values presented as Median [IQR] with Kruskal-Wallis test. A significance level of 0.0167 was used for pairwise ad-hoc comparisons. Septic shock defined by criteria of Bone et al. (18).
Significantly different from Septic Shock.
Significantly different from controls.
Significantly different from non-shock.
Data not available for all subjects. Missing values: C4 (n = 4), C4c/C4 (n = 4) C3 (n = 4), C3bc/c3 (n = 4), leukocyte count (n = 3), and CRP (n = 4).